[A controlled clinical trial of a new bladder spasmolytic drug--Urispadol].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D005260:Female; D005419:Flavonoids / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications; D010302:Parkinson Disease, Secondary / Q000150:complications; D010919:Placebos; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D001750:Urinary Bladder, Neurogenic / Q000150:complications; D014549:Urinary Incontinence / Q000188:drug therapy*; D014550:Urinary Incontinence, Stress / Q000188:drug therapy*; D014554:Urination / Q000187:drug effects; D014555:Urination Disorders / Q000209:etiology
D005419:Flavonoids; D010919:Placebos; D000644:Quaternary Ammonium Compounds
En kontrolleret klinisk undersgelse af et nyt blaerespasmolytikum--Urispadol.